- Investing Ideas
- South Korean Pharmaceuticals & Biotech Sustainable Track Record
South Korean Pharmaceuticals & Biotech Sustainable Track Record
Results
6
Companies which have reinvested earnings to sustain 10% yearly growth over 5 years.
6 companies
PharmaResearch
Market Cap: ₩3.7t
Operates as a biopharmaceutical company primarily in South Korea.
A214450
₩360,000.00
7D
7.0%
1Y
-37.8%
Samsung BiologicsLtd
Market Cap: ₩63.8t
Together with its subsidiaries engages in the manufacturing, commercializing, distributing, and selling of biopharmaceuticals products in South Korea, Europe, the United States, and internationally.
A207940
₩1,379,000.00
7D
-1.2%
1Y
-17.6%
Oscotec
Market Cap: ₩1.2t
Operates as a biotechnology company, engages in the drug development, functional materials and related products, and dental bone graft material businesses.
A039200
₩31,200.00
7D
3.5%
1Y
-8.6%
JW Shinyak
Market Cap: ₩110.7b
Engages in the research, development, production, and sale of medicines and medical supplies in South Korea.
A067290
₩1,982.00
7D
0.6%
1Y
24.5%
JW Holdings
Market Cap: ₩264.7b
Operates as a healthcare company in South Korea, the United States, Japan, China, and internationally.
A096760
₩3,825.00
7D
-2.0%
1Y
3.8%
SK Biopharmaceuticals
Market Cap: ₩6.2t
A pharmaceutical company, engages in the research, development, and commercialization of drugs for the treatment of central nervous system disorders.
A326030
₩79,700.00
7D
0.4%
1Y
-21.9%